Treatment
Medication clinical trials
We’re tracking 7,450 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT04619277Recruiting
Drug-coated balloon for a new coronary artery blockage
This trial studies whether a drug-coated balloon can treat a brand-new (de novo) blockage in the coronary arteries. If you may qualify, it could offer a way to reduce problems from this blockage using a device that delivers medicine during treatment.
UlsanAges Any age - NCT03980275Recruiting
Nerve-sparing surgery for both vocal cords that won’t move
This trial studies a surgical technique to improve breathing and voice in people whose both vocal cords do not move. It’s meant for cases that have not improved on their own for at least 6 months, and it may help restore better movement and function.
New York, New YorkAges 18–70 - NCT03916302Recruiting
Pulmonary embolism registry study in Warsaw
This study keeps a registry (record) of people with a confirmed pulmonary embolism. Your information helps doctors better understand the condition and improve care.
WarsawAges 18 years+ - NCT04025047Recruiting
Follow-up study after trans-vaginal mesh pelvic surgery
This study follows people who have pelvic reconstructive surgery using a trans-vaginal mesh to learn about possible complications over time. It may help improve care by tracking outcomes for up to 36 months.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04158895Recruiting
HIV care records study to improve HIV treatment in Malawi
This study gathers information from people receiving HIV care in Malawi to better understand and improve HIV treatment. You may be included if you are an adult or older and you are currently accessing HIV care during the study’s time period.
LilongweAges 15 years+ - NCT04149782Recruiting
HIV care records review in South Africa
This study gathers and reviews existing records from people receiving care for HIV in South Africa. It aims to better understand how HIV treatment is working in real-world settings and for different types of risk groups.
JohannesburgAges 15 years+ - NCT03882840RecruitingPhase 1/Phase 2
T-like NK cell therapy for cancers with low MHC-I
This early-stage trial tests a lab-made immune cell treatment (T-like NK cells) for advanced cancers that have low or missing MHC-I on their cells. Because the treatment aims to “re-activate” the immune system against these cancers, you may be eligible if your cancer matches this feature and you meet safety requirements.
Guangzhou, GuangdongAges 18 years+ - NCT04373057RecruitingPhase 1/Phase 2
Prebiotic fiber to prevent gut inflammation after transplant
This early-phase study tests a prebiotic (galacto-oligosaccharide) to see if it can lower or prevent gut inflammation caused by acute graft-versus-host disease (acute GVHD) after a stem cell transplant. If you’re scheduled for an allogeneic transplant, participating may help researchers find safer ways to protect your gut.
Kansas City, KansasAges 18–80 - NCT04312854Recruiting
Study of IRPF in adults in China
This study follows adults in China who have IRPF (idiopathic retroperitoneal fibrosis). It aims to better understand the condition and may help improve how it’s diagnosed and managed over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT04667078RecruitingPhase 3
Cangrelor plus thrombectomy to improve blood flow imaging in stroke
This Phase 3 trial tests whether adding a clot-fighting medicine called cangrelor to a mechanical clot-removal procedure (thrombectomy) can improve outcomes in selected acute stroke patients. It targets people whose scan shows there may be salvageable brain tissue, aiming to protect more brain while the clot is treated.
BesançonAges 18–80 - NCT04635891Recruiting
Study motor function tests in FSHD
This trial studies how well certain physical/movement tests work in people with facioscapulohumeral muscular dystrophy (FSHD). It may help clinicians measure changes more accurately and tailor care over time.
Los Angeles, CaliforniaAges Any age - NCT04075162Recruiting
Free heart calcium scan program at University Hospitals
This study is looking at people who already received a free coronary artery calcium (CAC) CT scan through a community screening program at University Hospitals. It may help the hospital understand who benefits from offering these no-cost scans.
Cleveland, OhioAges 18–100 - NCT04229043Recruiting
Test drink timing to study stomach emptying in late labor
This study measures how quickly a pregnant person’s stomach empties a water or sports drink during late labor. It may help improve safety and timing of what people can drink when labor is starting or being induced.
Boston, MassachusettsAges 18–50 - NCT04306458Recruiting
Testing robot-assisted vs standard surgery for resectable esophageal cancer
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
MainzAges 18–90 - NCT04255615Recruiting
AI tool to improve IVF and embryo freezing assessments
This study uses an artificial intelligence (computer) tool to look at results from IVF and related fertility treatments. It may help clinicians assess outcomes more accurately for people going through ovarian stimulation and embryo or egg freezing.
New York, New YorkAges 18–89 - NCT04628429Recruiting
Study CGRP blocker effects on migraine and body nerve function
This study tests a CGRP-blocking antibody to see how it affects migraine symptoms and the body’s automatic (involuntary) nerve functions. It may help people with migraine who have already tried several preventive medicines.
ViennaAges 18–64 - NCT04113356Recruiting
MRI study after first heart attack treated with fast angioplasty
This trial tests how well a heart MRI can be used soon after a first heart attack, especially when a blocked artery is opened quickly with angioplasty. It may help doctors better assess heart injury and guide care after an emergency heart event.
InnsbruckAges 18 years+ - NCT03849443RecruitingEarly Phase 1
Testing tranexamic acid to reduce bleeding after spine fusion
This trial studies whether a single dose or multiple doses of tranexamic acid (TXA) can reduce the chance you need a blood transfusion after spine fusion surgery. It also compares two different ways TXA may be given (by mouth and through a vein) to see which approach works best and is safe.
Chicago, IllinoisAges 18 years+ - NCT04085406Recruiting
Deep brain stimulation for hard-to-treat low back pain
This trial studies deep brain stimulation (DBS) to reduce severe low back pain that hasn’t improved after many standard treatments and procedures. It may help people whose pain is long-lasting and not fixable with another surgery.
Los Angeles, CaliforniaAges 40–75 - NCT03552562Recruiting
Eye blood-flow study in adults with type 2 diabetes
This study measures blood flow and oxygen use in the retina (the light-sensing layer at the back of your eye) in adults with type 2 diabetes and in healthy adults. It may help researchers better understand how diabetes affects the eye.
ViennaAges 18–99 - NCT04438525Recruiting
BAT test to replace sting challenge in venom allergy care
This study looks at whether a BAT (a blood test) can stand in for sting/venom “challenges” for people already receiving venom immunotherapy. If it works, it could help patients avoid more risky or uncomfortable challenge procedures while still checking whether treatment is working.
GrazAges 18–70 - NCT06841822Recruiting
Nerve blocks for lung surgery: a study on heart function
This trial tests if a special ultrasound-guided nerve block can help keep your heart and blood pressure stable during the start of lung surgery. It may lead to a safer and more comfortable experience.
Nanjing, JiangsuAges 18 years+ - NCT03919305Recruiting
Study of blood clots in brain veins
This study follows people who have a blood clot in the brain’s venous drainage system. It aims to better understand this condition and may help improve how it is recognized and managed.
BeijingAges Any age - NCT03821467Recruiting
Eye scan study to test a new imaging method in healthy adults
This study checks whether a specific eye-scanning technology gives consistent, repeatable results. It enrolls healthy adults to see if the test works reliably before being used more broadly.
Vienna, State of ViennaAges 18–35
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,450 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.